Small Split-Face Trial Finds Similar Melasma Improvement With Two 1064-nm Lasers
In 16 Asian women, picosecond and Q-switched Nd:YAG treatments produced improvement without a significant difference in six-month recurrence
Read More
Category: News
From Clinic to Bathroom Shelf: Classys Takes Shurink Home Into the US Market
The Korean aesthetic-device manufacturer has launched a consumer beauty range in America, bringing its professional brand recognition to a new market.
Read More
BTL launches its dedicated Laser Division and introduces EXOLASE ONE®
The world’s first fused erbium laser, bringing a new approach to laser facial rejuvenation BTL, a...
Read MoreSmall Renuvion Study Reports Changes in Skin-Tissue Markers after Helium Plasma RF
Apyx Medical has reported preliminary findings from a seven-patient prospective study of its Renuvion helium plasma radiofrequency technology in human tissue. The results offer insight into possible tissue remodelling but...
Read MoreINMODE Introduces Morpheus8 Cool Handpiece for RF Microneedling
InMode has launched Morpheus8 Cool, a new radiofrequency (RF) microneedling handpiece with a large-surface cooling tip and updated treatment controls. Announced on 9 September 2026, the device is available on...
Read More
Why Artificial Intelligence May Remind Us What It Means to Be Human
As artificial intelligence becomes increasingly capable of replicating human thought and creativity, Steven H. Dayan, MD, considers whether our greatest advantage may lie not in how we think, but in our deeply evolved ability to sense, connect with and understand one another
Read More
Building Bridges in Aesthetic Medicine China and the U.S.
As China and the U.S. continue to shape two of the world’s most dynamic aesthetic medicine markets, collaboration between their clinicians is creating opportunities to share knowledge, advance research and improve patient care
Read MoreGalderma Agrees $1.5 Billion Acquisition of ZO Skin Health
The proposed purchase would add ZO’s physician-dispensed skincare portfolio to Galderma’s dermatology business, subject to regulatory approval.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- ...
- 113
Sept/Oct 2026 Issue
